Search results for "Hemoglobin"

showing 10 items of 504 documents

Hematopoietic peripheral circulating blood stem cells as an independent marker of good transfusion management in patients with β-thalassemia: results…

2016

Background Beyond hemoglobin (Hb) levels and performance status, further surrogate markers of appropriate transfusion management should improve the quality of thalassemia care. We investigated the levels of peripheral circulating CD34+ stem cells as an independent marker of appropriate hematopoietic balance in patients with thalassemia. Study design and methods Peripheral circulating CD34+ stem cells, colony-forming unitgranulocyte, erythrocyte, macrophage, magakaryocyte (CF-GEMM), colony-forming unitgranulocyte/macrophage (CFU-GM), and erythroidburst-forming units (BFU-E) were assayed, according to standard procedures. Patients with thalassemia major (TM) and thalassemia intermedia (TI) we…

0301 basic medicinemedicine.medical_specialtyThalassemiamedicine.medical_treatmentImmunologyCD34Hematopoietic stem cell transplantationGastroenterology03 medical and health sciences0302 clinical medicineInternal medicinemedicineImmunology and Allergybusiness.industryBeta thalassemiaHematologymedicine.diseaseRed blood cellHaematopoiesis030104 developmental biologymedicine.anatomical_structureImmunologyHemoglobinStem cellbusiness030215 immunologyTransfusion
researchProduct

Effect of Whole-Body Cryotherapy on Morphological, Rheological and Biochemical Indices of Blood in People with Multiple Sclerosis

2021

The aim of this study was to examine and assess the impact of a series of 20 whole-body cryotherapy (WBC) treatments on the biochemical and rheological indices of blood in people with multiple sclerosis. In this prospective controlled study, the experimental group consisted of 15 women aged 34–55 (mean age, 41.53 ± 6.98 years) with diagnosed multiple sclerosis who underwent a series of whole-body cryotherapy treatments. The first control group consisted of 20 women with diagnosed multiple sclerosis. This group had no intervention in the form of whole-body cryotherapy. The second control group consisted of 15 women aged 30–49 years (mean age, 38.47 ± 6.0 years) without neurological diseases …

0301 basic medicinemedicine.medical_specialtymedicine.medical_treatmentBlood countCryotherapyHematocritmultiple sclerosisFibrinogenGastroenterologyArticle03 medical and health sciences0302 clinical medicineInternal medicinemedicineblood rheologyblood morphologymedicine.diagnostic_testbusiness.industryMultiple sclerosisRWhole body cryotherapyGeneral MedicineVenous bloodmedicine.diseasewhole-body cryotherapy030104 developmental biologyMedicineHemoglobinbusiness030217 neurology & neurosurgerymedicine.drugJournal of Clinical Medicine
researchProduct

Papel del estrés oxidativo y del tejido adiposo en la pancreatitis aguda experimental

2013

La pancreatitis aguda es un proceso inflamatorio agudo del páncreas con afectación variable de otros tejidos y sistemas orgánicos alejados. La incidencia de la pancreatitis aguda en la Unión Europea y Estados Unidos varía de 5 a 30 casos/100.000/año (Ellis y cols., 2009). La mortalidad en pacientes con pancreatitis aguda es alrededor del 5%, pero este porcentaje aumenta al 17-20% en pacientes con pancreatitis necrotizante (Pandol y cols., 2007). La participación del estrés oxidativo en la pancreatitis aguda se ha podido demostrar en la depleción precoz de glutatión reducido (GSH) y su precursor, la cisteína, que se mantiene y precede a la formación de edema pancreático. Este descenso en los…

:CIENCIAS MÉDICAS::Patología::Otras [UNESCO]pancreatitis agudapulmónestrés oxidativo:CIENCIAS DE LA VIDA::Fisiología humana::Fisiología de la digestión [UNESCO]lavado peritonealUNESCO::CIENCIAS DE LA VIDA::Fisiología humana::Fisiología de la digestiónhemoglobinatejido adiposoUNESCO::CIENCIAS MÉDICAS::Patología::Otrasobesidad
researchProduct

Central functional response to the novel peptide cannabinoid, hemopressin.

2013

Hemopressin is the first peptide ligand to be described for the CB₁ cannabinoid receptor. Hemopressin acts as an inverse agonist in vivo and can cross the blood-brain barrier to both inhibit appetite and induce antinociception. Despite being highly effective, synthetic CB₁ inverse agonists are limited therapeutically due to unwanted, over dampening of central reward pathways. However, hemopressin appears to have its effect on appetite by affecting satiety rather than reward, suggesting an alternative mode of action which might avoid adverse side effects. Here, to resolve the neuronal circuitry mediating hemopressin's actions, we have combined blood-oxygen-level-dependent, pharmacological-ch…

AM251MaleCannabinoid receptorHypothalamus MiddleNerve Tissue ProteinsNucleus accumbensSatiety ResponseRats Sprague-DawleyCellular and Molecular Neurosciencechemistry.chemical_compoundHemoglobinsMiceRandom AllocationPiperidinesReceptor Cannabinoid CB1Appetite DepressantsmedicineInverse agonistAnimalsPeriaqueductal GrayPharmacologyMice KnockoutNeuronsBehavior AnimalCannabinoidsHemopressinPeptide FragmentsRatsVentral tegmental areamedicine.anatomical_structurechemistryPyrazolesRaphe NucleiBrain stimulation rewardRaphe nucleiPsychologyNeuroscienceInjections Intraperitonealmedicine.drugNeuropharmacology
researchProduct

Structural and Dynamic Properties of the Homodimeric Hemoglobin from Scapharca inaequivalvis Thr-72→Ile Mutant: Molecular Dynamics Simulation, Low Te…

1998

AbstractMolecular dynamics simulations, low temperature visible absorption spectroscopy, and resonance Raman spectroscopy have been performed on a mutant of the Scapharca inaequivalvis homodimeric hemoglobin, where residue threonine 72, at the subunit interface, has been substituted by isoleucine. Molecular dynamics simulation indicates that in the Thr-72→Ile mutant several residues that have been shown to play a role in ligand binding fluctuate around orientations and distances similar to those observed in the x-ray structure of the CO derivative of the native hemoglobin, although the overall structure remains in the T state. Visible absorption spectroscopy data indicate that in the deoxy …

Absorption spectroscopyProtein subunitDimerResonance Raman spectroscopyMutantBiophysicsHemeSpectrum Analysis Ramanchemistry.chemical_compoundHemoglobinsMutant proteinAnimalsHemeHistidineCarbon MonoxideChemistrySettore BIO/11TemperatureWaterCrystallographyMolluscaSpectrophotometryMutationDimerizationProtein BindingResearch ArticleBiophysical Journal
researchProduct

Dependence of plasma pH on oxygen saturation

1969

Abstract The influence of haemoglobin oxygenation on the pH value of the blood plasma of healthy adolescents was investigated at 38°C by varying the parameters CO2 pressure, Hb concentration and buffer bases. A total of 5000 measurements gave the following results: 1. 1. The pHs difference between oxygenated and deoxygenated blood increases with diminishing CO2 pressure and with increasing Hb concentration. There is a linear relation between the pHs changes and the O2 saturation of the haemoglobin. 2. 2. Quantitatively these relationships can be expressed by the following equation: δpHs = (8 − pH ox − log 0.03 Pco 2 ) · [Hb] 225 · (100 − So 2 100 where ΔpHs is the pHs difference between par…

Acid-Base EquilibriumPulmonary and Respiratory MedicineAdolescentPhysiologyChemistryPartial PressureAnalytical chemistryOxygenationVenous bloodPlasmaBuffersCarbon DioxideHydrogen-Ion ConcentrationOxygenBicarbonatesHemoglobinsBloodBiochemistryBlood plasmaLinear relationHumansBase excessOxygen saturationBlood phRespiration Physiology
researchProduct

Comparison between a guaiac and three immunochemical faecal occult blood tests in screening for colorectal cancer

2012

Abstract Background The aim of this study was to compare the performance of the guaiac-based faecal occult blood test (G-FOBT), with that of three immunochemical faecal occult blood tests (I-FOBT) which allow automatic interpretation. Patients and methods Under the French organised screening programme, 85,149 average-risk individuals aged 50–74 participating in the third screening round, performed both the G-FOBT (Hemoccult-II test) and one of the I-FOBTs: FOB-Gold, Magstream and OC-Sensor. Results Given the chosen threshold, the positivity ratio between the different I-FOBTs and the G-FOBT was 2.4 for FOB-Gold, 2.0 for Magstream and 2.2 for OC-Sensor (P = 0.17). The three I-FOBTs were supe…

AdenomaMaleCancer Researchmedicine.medical_specialtyColorectal cancerhealth care facilities manpower and serviceseducationColonoscopyGastroenterologyScreening programmeFecesHemoglobinsPredictive Value of TestsInternal medicineBiomarkers TumormedicineHumansMass Screeninghealth care economics and organizationsAgedmedicine.diagnostic_testAdvanced adenomasbusiness.industryCarcinomaColonoscopyFaecal occult bloodMiddle Agedmedicine.diseaseImmunohistochemistrydigestive system diseasessurgical procedures operativeOncologyOccult BloodPredictive value of testsFemaleFranceDetection rateFaecal occult blood testColorectal NeoplasmsGuaiacbusinessEuropean Journal of Cancer
researchProduct

Impact of granulocyte colony-stimulating factor (G-CSF) and epoetin (EPO) on hematologic toxicities and quality of life in patients during adjuvant c…

2020

Hematologic toxicities are one of the greatest challenges in adjuvant chemotherapy for breast cancer. This analysis of the ADEBAR trial aims to evaluate application and effect of granulocyte colony-stimulating factor (G-CSF) and epoetin alfa (EPO) on hematologic parameters and fatigue in patients with breast cancer during chemotherapy.In the ADEBAR trial, 1493 patients with node-positive primary breast cancer were randomized to either 6 × 5-fluorouracil, epirubicin, and cyclophosphamide (FEC120) or 4 × epirubicin and cyclophosphamide followed by 4 × docetaxel (EC-DOC). Co-medication with G-CSF or EPO was applied to treat chemotherapy-induced leukopenia or anemia. Fatigue was assessed at bas…

Adult0301 basic medicineOncologyCancer Researchmedicine.medical_specialtyAdolescentCyclophosphamidemedicine.medical_treatmentBreast NeoplasmsSeverity of Illness IndexHemoglobinsLeukocyte CountYoung Adult03 medical and health sciences0302 clinical medicineBreast cancerInternal medicineAntineoplastic Combined Chemotherapy ProtocolsGranulocyte Colony-Stimulating FactormedicineHumansProspective StudiesFatigueAgedNeoplasm StagingChemotherapyLeukopeniabusiness.industryEpoetin alfaAnemiaLeukopeniaMiddle Agedmedicine.diseaseGranulocyte colony-stimulating factorEpoetin Alfa030104 developmental biologyOncologyDocetaxelChemotherapy Adjuvant030220 oncology & carcinogenesisQuality of LifeFemalemedicine.symptombusinessmedicine.drugEpirubicin
researchProduct

Dosage individualization of erythropoietin using a profile-dependent support vector regression

2003

The external administration of recombinant human erythropoietin is the chosen treatment for those patients with secondary anemia due to chronic renal failure in periodic hemodialysis. The objective of this paper is to carry out an individualized prediction of the EPO dosage to be administered to those patients. The high cost of this medication, its side-effects and the phenomenon of potential resistance which some individuals suffer all justify the need for a model which is capable of optimizing dosage individualization. A group of 110 patients and several patient factors were used to develop the models. The support vector regressor (SVR) is benchmarked with the classical multilayer percept…

AdultAnemia HemolyticInjections SubcutaneousAutoregressive conditional heteroskedasticityBiomedical EngineeringMachine learningcomputer.software_genreCohort StudiesHemoglobinsRenal DialysisFeature (machine learning)HumansMedicineSensitivity (control systems)Time seriesErythropoietinAgedAged 80 and overArtificial neural networkbusiness.industryMiddle AgedRecombinant ProteinsRegressionDrug Therapy Computer-AssistedRegression PsychologySupport vector machineTreatment OutcomeMultilayer perceptronKidney Failure ChronicNeural Networks ComputerArtificial intelligencebusinesscomputerAlgorithmsBiomedical engineeringIEEE Transactions on Biomedical Engineering
researchProduct

Standard vs Distal Roux-en-Y Gastric Bypass in Patients With Body Mass Index 50 to 60: A Double-blind, Randomized Clinical Trial.

2016

Up to one-third of patients undergoing bariatric surgery have a body mass index (BMI) of more than 50. Following standard gastric bypass, many of these patients still have a BMI greater than 40 after peak weight loss.To assess the efficacy and safety of standard gastric bypass vs distal gastric bypass in patients with a BMI of 50 to 60.Double-blind, randomized clinical parallel-group trial at 2 tertiary care centers in Norway (Oslo University Hospital and Vestfold Hospital Trust) between May 2011 and April 2013. The study included 113 patients with a BMI of 50 to 60 aged 20 to 60 years. The 2-year follow-up was completed in May 2015.Standard gastric bypass (alimentary limb, 150 cm) and dist…

AdultBlood GlucoseDiarrheaMalemedicine.medical_specialtyGastric Bypass030209 endocrinology & metabolismGastroenterologyProtein-Energy Malnutritionlaw.inventionBody Mass Index03 medical and health sciencesYoung Adult0302 clinical medicineRandomized controlled trialQuality of lifeDouble-Blind MethodlawWeight lossDiabetes mellitusInternal medicineWeight LossmedicineHumans030212 general & internal medicineAdverse effectGlycated HemoglobinSleep Apnea Obstructivebusiness.industryHyperparathyroidismCholesterol LDLMiddle Agedmedicine.diseaseRoux-en-Y anastomosisObesitySurgeryObesity MorbidDiabetes Mellitus Type 2HypertensionQuality of LifeSurgeryFemalemedicine.symptombusinessBody mass indexFollow-Up StudiesJAMA surgery
researchProduct